ESTRO 2023 - Abstract Book

S45

Saturday 13 May

ESTRO 2023

The percentage of paediatric cancers is more than 6 times higher in Middle Eastern countries (mean for 4 countries: 3.14%; Kuwait: 2.69%, Jordan: 2.9%, Egypt: 3.12% and Saudi Arabia: 3.86%) compared to 4 developed countries (mean: 0.51% in UK, USA, France and Australia). The number of paediatric cancer patients who would benefit from PBT annually in Middle Eastern countries is: Kuwait (N=34), Jordan (N=139), Egypt (N=1,912) and Saudi Arabia (N=384). The number (and percentage) of additional adult cancer patients treated with curative-intent radiotherapy who would benefit from PBT annually in Middle Eastern countries was: Kuwait: 98 (10.55%), Jordan: 395 (13.3%), Egypt: 2,756 (11.1%) and Saudi Arabia: 643 (10.55%); Table 1 and Figure 1. The modelled estimated total cost of a 2-4 gantry PBT facility in Middle Eastern countries was: Kuwait $105m, Jordan $99m, Egypt $89m and Saudi Arabia $101m. Therefore, the cost of establishing a PBT centre would represent 0.093% of Kuwait’s GDP, 0.3% of Jordan’s GDP, 0.035% of Egypt’s GDP and 0.018% of Saudi Arabia’s GDP (mean for 4 countries: 0.11%). This is 27 times more than the average cost as a share of GDP in 4 developed countries (UK, USA, France and Australia). Assuming a lifetime of 20 years for the PBT centre, the cost of PBT per patient in Middle Eastern countries is: Kuwait: $51,746, Jordan: $31,589, Egypt: $25,936 and Saudi Arabia: $43,823.

Table 1

Figure 1

Conclusion We report important information on the demand for PBT services and the economic costs of establishing PBT centres in Middle Eastern countries. Our findings could guide future healthcare policy planning in our region. PD-0081 Research culture in Australian and New Zealand radiation oncology: fact or fantasy? D. Roos 1,2 1 Royal Adelaide Hospital, Radiation Oncology, Adelaide, Australia; 2 University of Adelaide, School of Medicine, Adelaide, Australia Purpose or Objective Fostering a research culture is a key goal of the Royal Australian and New Zealand College of Radiologists yet there has never been an organisation-wide enquiry into the extent to which this is being realised, nor has there been in corresponding societies overseas. The purpose of this work was to comprehensively address that deficit for the Radiation Oncology (RO) Faculty to serve as a baseline for future comparison, given that the College’s Research Action Plan is being updated in 2022. The hypothesis was that such a culture is closer to fact than fantasy, acknowledging that this is a subjective call in the absence of comparative data.